A Phase II Study of MOAD (Methotrexate, Vincristine, L-asparaginase and Dexamethasone) With Subcutaneous Campath for Adults With Relapsed or Refractory Acute Leukemia (ALL)
OBJECTIVES:
I. Determine the complete response rate in patients with relapsed or refractory acute
lymphoblastic leukemia treated with methotrexate, vincristine, asparaginase, and
dexamethasone (MOAB) in combination with alemtuzumab.
II. Determine disease-free and/or overall survival of patients treated with this regimen.
III. Determine the toxic effects of this regimen in these patients. IV. Correlate the
density of CD52 molecules on the surface of leukemic lymphoblasts with response in patients
treated with this regimen.
V. Correlate the presence of minimal residual disease at the time of maximal response to
this regimen with overall outcome in these patients.
OUTLINE: This is a multicenter study.
INDUCTION THERAPY: Patients receive methotrexate IV on day 1; vincristine IV and
asparaginase intramuscularly (IM) on day 2; oral dexamethasone on days 1-10; and alemtuzumab
subcutaneously on days 1, 4, and 7. Treatment repeats every 10 days for 6 courses in the
absence of disease progression or unacceptable toxicity. Patients who achieve complete
remission (CR proceed to consolidation therapy.
CONSOLIDATION THERAPY: Patients receive methotrexate IV on day 1 and asparaginase IM on day
2. Treatment repeats every 10 days for 6 courses in the absence of disease progression or
unacceptable toxicity. Patients who remain in CR proceed to cytoreduction therapy.
CYTOREDUCTION THERAPY: Patients receive vincristine IV and methotrexate IV over 6 hours on
day 1; leucovorin calcium IV continuously over 24 hours on days 1 and 2 and then orally 4
times a day on day 3; and oral dexamethasone on days 2-6. Treatment repeats every 30 days
for 12 courses in the absence of disease progression or unacceptable toxicity. Patients who
remain in CR proceed to maintenance therapy.
MAINTENANCE THERAPY: Patients receive oral mercaptopurine on days 1-30; oral methotrexate on
days 1, 8, 15, and 22; vincristine IV on day 1; and oral dexamethasone on days 1-5.
Treatment repeats every 30 days for 36 courses in the absence of disease progression or
unacceptable toxicity.
After completion of study treatment, patients are followed periodically for 5 years from the
date of registration to this study.
Interventional
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Complete response rate for MOAD in combination with Campath in adult patients with relapsed or refractory ALL
With this two-stage design, the probability of stopping at the end of the first stage is 0.60 if the true response rate is 50%, but is 0.04 if the true response rate is 75%; this design has a power of 92% and a one-sided type I error of 0.09. The response at another dose level of Campath will be described in technical report separately.
After 6 courses of induction treatment, assessed up to 5 years
No
Peter Wiernik
Principal Investigator
Eastern Cooperative Oncology Group
United States: Food and Drug Administration
NCI-2009-00518
NCT00262925
June 2006
Name | Location |
---|---|
Fairview Ridges Hospital | Burnsville, Minnesota 55337 |
Hutchinson Area Health Care | Hutchinson, Minnesota 55350 |
United Hospital | St. Paul, Minnesota 55102 |
Ridgeview Medical Center | Waconia, Minnesota 55387 |
Geisinger Medical Center | Danville, Pennsylvania 17822-0001 |
Via Christi Regional Medical Center | Wichita, Kansas 67214 |
Wesley Medical Center | Wichita, Kansas 67214 |
University of Wisconsin Hospital and Clinics | Madison, Wisconsin 53792-0001 |
Montefiore Medical Center | Bronx, New York 10467-2490 |
Lewistown Hospital | Lewistown, Pennsylvania 17044 |
Mount Nittany Medical Center | State College, Pennsylvania 16803 |
Cancer Center of Kansas - Chanute | Chanute, Kansas 66720 |
Cancer Center of Kansas - Dodge City | Dodge City, Kansas 67801 |
Cancer Center of Kansas - Newton | Newton, Kansas 67114 |
Cancer Center of Kansas - Salina | Salina, Kansas 67042 |
Cancer Center of Kansas - Wellington | Wellington, Kansas 67152 |
Associates in Womens Health | Wichita, Kansas 67203 |
Cancer Center of Kansas - Winfield | Winfield, Kansas 67156 |
Mercy Hospital and Medical Center | Chicago, Illinois 60616 |
Mercy Hospital | Coon Rapids, Minnesota 55433 |
Fairview-Southdale Hospital | Edina, Minnesota 55435 |
Abbott-Northwestern Hospital | Minneapolis, Minnesota 55407 |
Regions Hospital | Saint Paul, Minnesota 55101 |
Saint Francis Regional Medical Center | Shakopee, Minnesota 55379 |
Rice Memorial Hospital | Willmar, Minnesota 56201 |
Geisinger Medical Group | State College, Pennsylvania 16801 |
Cancer Center of Kansas - Fort Scott | Fort Scott, Kansas 66701 |
Cancer Center of Kansas-Independence | Independence, Kansas 67301 |
Lawrence Memorial Hospital | Lawrence, Kansas 66044 |
Hennepin County Medical Center | Minneapolis, Minnesota |
Case Western Reserve University | Cleveland, Ohio 44106 |
Wichita CCOP | Wichita, Kansas 67214-3882 |
Metro-Minnesota CCOP | St. Louis Park, Minnesota |
Lakeview Hospital | Stillwater, Minnesota 55082 |
Penn State Milton S Hershey Medical Center | Hershey, Pennsylvania 17033 |
Rush - Copley Medical Center | Aurora, Illinois 60504 |
Joliet Oncology-Hematology Associates Limited | Joliet, Illinois 60435 |
Edward H Kaplan MD and Associates | Skokie, Illinois 60076 |
Carle Clinic-Urbana Main | Urbana, Illinois 61801 |
Saint Anthony Memorial Health Center | Michigan City, Indiana 46360 |
Mercy Medical Center-Sioux City | Sioux City, Iowa 51104 |
Saint Luke's Regional Medical Center | Sioux City, Iowa 51104 |
Cancer Center of Kansas - El Dorado | El Dorado, Kansas 67042 |
Cancer Center of Kansas-Kingman | Kingman, Kansas 67068 |
Cancer Center of Kansas - Parsons | Parsons, Kansas 67357 |
Cancer Center of Kansas - Pratt | Pratt, Kansas 67124 |
Cancer Center of Kansas-Wichita Medical Arts Tower | Wichita, Kansas 67208 |
Cancer Center of Kansas - Main Office | Wichita, Kansas 67214 |
Unity Hospital | Fridley, Minnesota 55432 |
Saint John's Hospital - Healtheast | Maplewood, Minnesota 55109 |
Minnesota Oncology Hematology PA-Maplewood | Maplewood, Minnesota 55109 |
North Memorial Medical Health Center | Robbinsdale, Minnesota 55422 |
Park Nicollet Clinic - Saint Louis Park | Saint Louis Park, Minnesota 55416 |
Minnesota Oncology and Hematology PA-Woodbury | Woodbury, Minnesota 55125 |
Geisinger Wyoming Valley | Wilkes-Barre, Pennsylvania 18711 |
Cancer Center of Kansas-Liberal | Liberal, Kansas 67901 |
Siouxland Hematology Oncology Associates | Sioux City, Iowa 51101 |
Geisinger Medical Center-Cancer Center Hazelton | Hazleton, Pennsylvania 18201 |